Kamada (KMDA) FCF Payout Ratio Growth (1y) (2014 - 2026)
Kamada (KMDA) FCF Payout Ratio Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | -14.68% |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | -49.97% |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -49.30% |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Kamada | 464.05 Mn | 434.58 Mn | 22.47 Mn | -52.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -52.94% |
| Mar 31, 2026 | -39.54% |
| Sep 30, 2025 | 73.76% |
| Jun 30, 2025 | -134.50% |
| Mar 31, 2025 | 513.31% |
| Dec 31, 2024 | 37.06% |
| Sep 30, 2024 | -85.10% |
| Jun 30, 2024 | -56.45% |
| Mar 31, 2024 | 183.23% |
| Dec 31, 2023 | -98.40% |
| Sep 30, 2023 | 351.48% |
| Jun 30, 2023 | 158.44% |
| Mar 31, 2023 | -525.64% |
| Dec 31, 2022 | 131.75% |
| Sep 30, 2022 | 105.06% |
| Jun 30, 2022 | 108.43% |
| Dec 31, 2021 | -9,297.66% |
| Sep 30, 2021 | -737.87% |
| Jun 30, 2021 | -813.63% |
| Dec 31, 2020 | -25.81% |